EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions

Albert Pons-Escoda, Pablo Naval-Baudin, Mildred Viveros, Susanie Flores-Casaperalta, Ignacio Martinez-Zalacaín, Gerard Plans, Noemi Vidal, Monica Cos, Carles Majos

Neuroradiology · 2024

DOI: 10.1007/s00234-024-03385-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroradiology, 2024. Verfasst von Albert Pons-Escoda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain. albert.pons@bellvitgehospital.cat. Hauptthemen laut MEDLINE: Glioblastoma, Astrocytoma, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The presurgical discrimination of IDH-mutant astrocytoma grade 4 from IDH-wildtype glioblastoma is crucial for patient management, especially in younger adults, aiding in prognostic assessment, guiding molecular diagnostics and surgical planning, and identifying candidates for IDH-targeted trials. Despite its potential, the full capabilities of DSC-PWI remain underexplored. This research evaluates the differentiation ability of relative-cerebral-blood-volume (rCBV) percentile values for the enhancing and non-enhancing tumor regions compared to the more commonly used mean or maximum preselected rCBV values.

Methods

This retrospective study, spanning 2016–2023, included patients under 55 years (age threshold based on World Health Organization recommendations) with grade 4 astrocytic tumors and known IDH status, who underwent presurgical MR with DSC-PWI. Enhancing and non-enhancing regions were 3D-segmented to calculate voxel-level rCBV, deriving mean, maximum, and percentile values. Statistical analyses were conducted using the Mann-Whitney U test and AUC-ROC.

Results

The cohort consisted of 59 patients (mean age 46; 34 male): 11 astrocytoma-4 and 48 glioblastoma. While glioblastoma showed higher rCBV in enhancing regions, the differences were not significant. However, non-enhancing astrocytoma-4 regions displayed notably higher rCBV, particularly in lower percentiles. The 30th rCBV percentile for non-enhancing regions was 0.705 in astrocytoma-4, compared to 0.458 in glioblastoma ( p = 0.001, AUC-ROC = 0.811), outperforming standard mean and maximum values.

Conclusion

Employing an automated percentile-based approach for rCBV selection enhances differentiation capabilities, with non-enhancing regions providing more insightful data. Elevated rCBV in lower percentiles of non-enhancing astrocytoma-4 is the most distinguishable characteristic and may indicate lowly vascularized infiltrated edema, contrasting with glioblastoma’s pure edema.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaAstrocytomaBrain NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultNeoplasm GradingDiagnosis, DifferentialMagnetic Resonance ImagingCerebral Blood VolumePreoperative Care

Stichwörter der Autor:innen

AstrocytomaBrain neoplasmsGlioblastomaMagnetic resonance imagingPerfusion imaging

Autor:innen und Institutionen

  • Radiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain. albert.pons@bellvitgehospital.cat.
  • Neuro-oncology Unit, Institut d'Investigació Biomèdica de Bellvitge- IDIBELL, Barcelona, Spain. albert.pons@bellvitgehospital.cat.
  • Facultat de Medicina i Ciències de La Salut, Universitat de Barcelona (UB), Barcelona, Spain. albert.pons@bellvitgehospital.cat.
  • Radiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Facultat de Medicina i Ciències de La Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • Diagnostic Imaging and Nuclear Medicine Research Group, Institut d'Investigació Biomèdica de Bellvitge- IDIBELL, Barcelona, Spain.

Förderung

  • Universitat de Barcelona

Zitieren

APA

Pons-Escoda, A., Naval-Baudin, P., Viveros, M., Flores-Casaperalta, S., Martinez-Zalacaín, I., Plans, G., Vidal, N., Cos, M., & Majos, C. (2024). DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions. Neuroradiology. https://doi.org/10.1007/s00234-024-03385-0

Vancouver

Pons-Escoda A, Naval-Baudin P, Viveros M, Flores-Casaperalta S, Martinez-Zalacaín I, Plans G, et al. DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions. Neuroradiology. 2024. doi:10.1007/s00234-024-03385-0

BibTeX
@article{PonsEscoda2024,
  author = {Pons-Escoda, Albert and Naval-Baudin, Pablo and Viveros, Mildred and Flores-Casaperalta, Susanie and Martinez-Zalacaín, Ignacio and Plans, Gerard and Vidal, Noemi and Cos, Monica and Majos, Carles},
  title = {DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions},
  journal = {Neuroradiology},
  year = {2024},
  doi = {10.1007/s00234-024-03385-0}
}
Kostenlos starten →